|
|
Institutional Career Development Core |
| 2KL2TR002317-06 |
|
NCATS |
2022 |
|
|
North Carolina Translational and Clinical Science Institute (NC TraCS) KL2 |
| 5KL2TR002490-05 |
|
NCATS |
2022 |
|
|
Institutional Career Development Core |
| 5KL2TR002530-05 |
|
NCATS |
2022 |
|
|
Institutional Career Development Core |
| 5KL2TR002534-05 |
|
NCATS |
2022 |
|
|
Harnessing Clinical Genomic Characterization to Accelerate Translational Advances for Patients with IDD |
| 5U01TR002764-03 |
|
NCATS |
2022 |
|
|
A consortium effort to translate therapies for neurological diseases via an ex vivo organotypic platform |
| 5U01TR003715-02 |
|
NCATS |
2022 |
|
|
Emerging therapeutic candidates for rare maternally inherited mitochondrial diseases with shared etiologies |
| 5UG3TR003897-02 |
|
NCATS |
2022 |
|
|
Targeted in vivo perturbation for dissecting tissue immune responses |
| 2U19AI128949-06 |
|
NIAID |
2022 |
|
|
Clinical Core |
| 2U19AI128949-06 |
|
NIAID |
2022 |
|
|
Project 2: T Cell Costimulation: Induction and Regulation of Autoimmunity |
| 5P01AI056299-19 |
|
NIAID |
2022 |